Inventis Bio has recently completed a series D financing of over RMB1 billion. This round of financing was led by Hillhouse Ventures, Qiming Ventures, Janchor, AIHC Capital, Matrix Partners China, Deyi Capital, E Fund Capital and other institutions also participated. The existing shareholders Eli Lilly Asia Fund, Aobo Capital, Pudong Science and Technology, Shanghui Capital, […]
Cancer Innovative Drug Startup Inventis Bio Secures Over RMB1 Billion comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.